YOLFTbeta
SKAN Group AG

SKAN Group AG

SKAN · SW · Healthcare / Medical Instruments & Supplies

68.60CHF-0.80 (-1.15%)

Price History

Full chart

Market Stats

Previous Close69.40
Open69.20
Day Range68.10 – 69.30
52-Week Range35.58 – 70.70
Volume15.22K
Market Cap1.52B
P/E (TTM)51.76
Forward P/E62.89
EPS1.31
Dividend Yield0.32%
Beta0.74
50-Day Avg63.14
200-Day Avg54.18

About

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard. It also provides digital solutions, lifecycle support, laboratory services, and SKAN labs. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jonas Greutert
  • Employees1.69K
  • HeadquartersKreuzstrasse 5, Allschwil, Switzerland, 4123, Switzerland
  • Websitehttps://skan.com/de/home/

Leadership

  • Mr. Thomas HuberExecutive Director · b. 1966
  • Mr. Jonas GreutertChief Executive Officer · b. 1972
  • Mr. Burim MarajChief Financial Officer · b. 1982
  • Ms. Nicole ProginHead of Global HR · b. 1972
  • Mr. Philippe JeromeHead of Equipment & Solutions · b. 1976
  • Mr. Martin E. SteegmullerHead of Service, Digital & Single-Use Systems · b. 1973

Financials

Income Statement

Currency: CHF2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.31M3.10M5.66M20.27M15.40M1.95M2.85M3.76M191.69M234.26M276.95M320.02M361.30M333.33M
Growth (%)--28.12%+82.55%+258.03%-23.99%-87.36%+46.57%+31.61%+5001.50%+22.21%+18.22%+15.55%+12.90%-7.74%
Cost of Revenue----2.89M746.32K707.39K-3.98M8.93K58.68M64.16M76.46M85.94M95.42M103.03M
Gross Profit4.31M3.10M5.66M23.16M14.66M1.24M6.83M3.75M133.00M170.11M200.50M234.08M265.88M230.31M
Gross Margin100.00%100.00%100.00%114.26%95.16%63.68%239.31%99.76%69.39%72.61%72.39%73.15%73.59%69.09%
Operating Expense780.04K748.78K836.06K4.70M-1.48M-13.96M1.22M-14.21M122.31M147.05M171.03M196.33M221.39M204.88M
Operating Income3.53M2.35M4.82M18.45M16.14M15.20M5.61M17.96M10.70M23.05M29.46M37.75M44.48M25.43M
Operating Margin81.92%75.85%85.23%91.05%104.78%780.39%196.41%478.03%5.58%9.84%10.64%11.80%12.31%7.63%
EBITDA3.54M2.36M4.48M18.45M16.14M19.09M6.08M18.13M16.48M32.38M40.15M50.14M59.68M36.03M
EBITDA Margin81.97%76.25%79.09%91.06%104.81%980.13%212.90%482.37%8.60%13.82%14.50%15.67%16.52%10.81%
Net Income3.52M2.24M4.48M18.45M15.97M15.20M5.76M17.96M4.53M10.62M18.99M26.31M38.80M16.27M
Net Income Margin81.65%72.37%79.09%91.03%103.67%780.39%201.85%477.85%2.36%4.53%6.86%8.22%10.74%4.88%
R&D-------4.788.83M15.20M19.05M23.33M--
R&D as % of Total Revenue-------0.00%4.61%6.49%6.88%7.29%--
Interest Expense-------6.85K109.00K132.00K464.00K362.00K412.00K1.49M
Interest Expense % of Total Revenue-------0.18%0.06%0.06%0.17%0.11%0.11%0.45%

Balance Sheet

Currency: CHF2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets73.05M83.65M88.20M77.01M72.08M87.35M96.50M112.57M259.54M331.92M388.35M373.45M384.49M481.08M
Total Liabilities237.39K224.39K1.34M509.02K909.15K784.46K2.61M637.47K176.98M157.92M222.76M197.09M181.92M353.49M
Total Equity72.77M83.39M86.81M76.50M71.17M86.57M93.89M111.93M41.65M159.75M157.30M169.23M196.16M114.45M
Cash5.53M4.58M899.27K7.65M10.87M10.55M406.90K1.82M63.82M131.54M110.98M85.12M53.71M94.08M
Total Debt--1.00M---2.10M-7.45M15.27M16.88M6.49M10.61M131.47M
Net Debt-5.53M-4.58M100.73K-7.65M-10.87M-10.55M1.69M-1.82M-56.37M-116.27M-94.10M-78.63M-43.10M37.39M

Cash Flow

Currency: CHF2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.16M690.79K242.35K-42.74K1.34M983.90K2.27M2.22M22.63M10.32M61.48M8.70M46.70M64.11M
Investing Cash Flow--10.00M-3.87M36.55M23.18M-1.50M-16.07M1.21M-15.95M-11.02M-76.42M-17.35M-69.06M-130.91M
Financing Cash Flow-1.37M8.37M-56.49K-29.75M-21.30M199.61K3.65M-2.01M-8.15M67.48M-4.85M-15.80M-9.35M108.99M
Capital Expenditure0002.03K12.34K00014.56M42.61M28.86M35.30M53.79M43.10M
Free Cash Flow1.16M690.79K242.35K-44.77K1.33M983.90K2.27M2.22M8.07M-32.29M32.62M-26.60M-7.09M21.01M
Dividends Paid--1.05M13.60M----010.62M5.40M5.62M7.87M8.99M
FCF to OCF100.00%100.00%100.00%104.75%99.08%100.00%100.00%100.00%35.65%-312.98%53.05%-305.72%-15.18%32.77%
Dividend Paid to FCF--431.51%-30374.06%----0.00%-32.88%16.54%-21.13%-111.00%42.81%

Earnings

Report DateFeb 11, 2019Sep 11, 2019Feb 13, 2020Jul 28, 2020Feb 5, 2021Aug 24, 2021Apr 5, 2022Aug 23, 2022Mar 28, 2023Mar 24, 2025Aug 19, 2025Mar 24, 2026Mar 23, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.00---
EPS Actual0.290.291.410.211.020.320.49-0.020.871.12-0.401.12-
Surprise-------------
Timing--After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.52B
Enterprise Value1.59B
Trailing P/E51.76
Forward P/E62.89
Price / Sales4.20
Price / Book13.65
EPS1.31
Book Value5.06
Revenue (TTM)363.25M
Gross Profit (TTM)272.15M
EBITDA49.83M
Profit Margin8.25%
Operating Margin5.27%
Return on Equity20.25%
Return on Assets5.66%
Shares Outstanding22.48M
Shares Float12.70M
Beta0.74
Dividend Yield0.32%
Dividend Rate0.22
Payout Ratio19.65%

Dividends

20261×
0.22May 11, 2026
20251×
0.40May 9, 2025
20242×
0.35May 10, 20240.17May 7, 2024
20231×
0.25May 5, 2023
20221×
0.24May 6, 2022